Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17342264 | 1.00 | POLB (0.46) | POLBCHRM2CHRM1CHRM3HSD11B1 | |
| SCHEMBL17342262 | 1.00 | POLB (0.46) | POLBCHRM2CHRM1CHRM3HSD11B1 | |
| SCHEMBL7027351 | 0.79 | POLB (0.58) | POLBCHRM2CHRM1CHRM3APEX1 | |
| SCHEMBL15097163 | 0.78 | POLB (0.43) | POLBCHRM2CHRM1CHRM3MAPK1 | |
| SCHEMBL17342272 | 0.78 | POLB (0.43) | POLB | |
| SCHEMBL17342259 | 0.78 | POLB (0.43) | POLB | |
| SCHEMBL19449156 | 0.76 | POLB (0.42) | POLB | |
| SCHEMBL12897708 | 0.76 | POLB (0.42) | POLBCYP2D6 | |
| SCHEMBL17342258 | 0.76 | BRD4 (0.46) | POLBCYP2C19 | |
| SCHEMBL15188003 | 0.76 | POLB (0.69) | POLBHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3892621-A1 | HALOALLYLAMINE COMPOUNDS AND APPLICATION THEREOF | Nanjing Transthera Biosciences Co., Ltd. (CN) | 2021-10-13 | — | — | EP | disclosed |
| EP-3233858-A1 | ERK INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016100050-A1 | ERK INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2016-06-23 | — | — | WO | disclosed |